Cost-effectiveness of elimination of HPV-cancers

Home

Related articles

HPV self-sampling is here

P Snijders
Costs and benefits of combined programs of screening and vaccination

P Nieminen
Elimination of cervical cancer from Europe

X Bosch
Screening of HPV vaccinated women

E Franco
Overall protection generated by gender-neutral HPV vaccination

M Lehtinen
Elimination of cervical cancer from developing countries

S Franceschi
From disease elimination to elimination of the oncogenic HPVs

P Nieminen
Elimination of HPV from different countries

I Baussano
Systematic review of studies on HPV type-replacement after generalized vaccination

D Mesher
The impact of HPV vaccination program on CIN3 and cervical cancer incidence in England

K. Soldan, L. Elliss-Brookes, P. Sasieni
HPV vaccination and the risk of invasive cervical cancer

J Lei, A Ploner, P Sparen
The time to act is now: elimination of cervical and other cancers caused by HPV in women and men

AR Giuliano, EA Joura
Interview with Julie Torode. WHO’s cervical cancer elimination campaign in developing countries (part 1)

J Torode
Clinical manifestations of HPV- associated disease: a South African perspective

TS Adams, L Denny
Interview with Margaret Stanley

M. Stanley
IPVS Statement on HPV Vaccination of Immunocompromised Hosts

Garland & IPVS Policy Committee
HPV 2020: the personal perspective of Dr. Joakim Dillner

J. Dillner
Interview with Julie Torode. WHO’s cervical cancer elimination campaign in developing countries (part 2)

J Torode
EU Joint Action on HPV Vaccination boosts HPV-related disease elimination plan

G Finnegan
Elimination of cervical cancer: a South African perspective

L. Denny

HOME
Published material
Remembering our colleagues
About us
Contact us

Login

Change email Change password Activate service

Did you forget your password?

Do you want to subscribe?

Legal notice Privacy Policy

Copyright © 2023 HPV World All rights reserved